This patient requires ADMISSION with URGENT UROLOGIC CONSULTATION for bladder catheterization and treatment with tamsulosin (Flomax), NOT furosemide (Lasix).
The primary issue is obstructive uropathy from prostatic enlargement causing acute urinary retention with secondary hydronephrosis and acute kidney injury—this is a urologic emergency requiring relief of obstruction, not diuresis.
Why Flomax (Tamsulosin), Not Lasix (Furosemide)
Tamsulosin is the appropriate treatment because this patient has acute urinary retention (AUR) from benign prostatic obstruction. Alpha-blockers like tamsulosin improve the success rate of voiding after catheter removal in AUR patients—from 26-28% with placebo to 48-61% with tamsulosin 1, 2. The medication works by relaxing prostatic smooth muscle, facilitating bladder emptying.
Furosemide is contraindicated in this clinical scenario. The FDA label explicitly warns: "In patients with severe symptoms of urinary retention (because of bladder emptying disorders, prostatic hyperplasia, urethral narrowing), the administration of furosemide can cause acute urinary retention related to increased production and retention of urine" 3. Additionally, furosemide is contraindicated in anuria 3, and this patient effectively has functional anuria from complete obstruction.
Critical Management Steps
Immediate Actions (Emergency Department/Admission):
Bladder catheterization - This is the definitive first step to relieve obstruction and decompress the upper urinary tract
- Monitor initial drainage volume
- Consider gradual decompression if volume >1000mL to prevent hematuria ex vacuo
- Leave catheter in place initially
Start tamsulosin 0.4mg daily - Begin immediately after catheterization 4, 1
Monitor renal function closely - With eGFR 28 and creatinine 2.43, expect improvement after obstruction relief
- Check electrolytes, creatinine daily initially
- The hydronephrosis should improve once obstruction is relieved
- Post-obstructive diuresis may occur—replace fluids appropriately if this develops
Urologic consultation - Essential for:
- Confirming prostatic obstruction as cause
- Planning definitive management (likely TURP or other surgical intervention)
- Determining timing of catheter removal trial
Why Admission is Mandatory:
- Acute kidney injury (eGFR 28, Cr 2.43) from obstructive uropathy requires monitoring
- Hydronephrosis indicates upper tract involvement—risk of permanent renal damage if not promptly relieved
- Post-obstructive diuresis may occur after catheterization, requiring IV fluid management
- Trial without catheter should occur in monitored setting given renal impairment
Common Pitfalls to Avoid
Do NOT give diuretics in urinary retention. The heart failure guidelines 5, 6 discuss furosemide use in volume overload states, but explicitly note that urinary obstruction is a reversible cause of worsening renal function that must be addressed first 7. The Canadian guidelines specifically state: "Systemic factors such as sepsis and urinary obstruction (especially chronic) are also important" causes of renal dysfunction that require correction 7.
Do NOT assume this is volume overload requiring diuresis. While the patient has retention, this is urinary retention (inability to void), not fluid retention from heart failure. The pathophysiology is completely different—obstruction prevents urine from leaving the bladder, backing up into the kidneys.
Do NOT delay catheterization. Every hour of continued obstruction risks further renal damage. The hydronephrosis indicates the kidneys are already under pressure.
Expected Clinical Course
After catheter placement and starting tamsulosin:
- Renal function should improve over 24-72 hours as obstruction is relieved
- Hydronephrosis should begin resolving on repeat imaging
- After 3-7 days of alpha-blocker therapy, attempt TWOC 4, 1
- If TWOC fails (likely given large prostate and retention), proceed to definitive surgical management (TURP or alternative procedure)
The key principle: treat the obstruction first, then address the consequences. Furosemide would worsen the situation by increasing urine production that cannot be voided, while tamsulosin addresses the underlying pathophysiology of prostatic obstruction 8, 9, 4.